Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Abstract Text:

Andy C Rawstron,Richard A Jones,Carol Ferguson,Geraint Hughes,Pam Selby,Carol Reid,Surita Dalal,Martin Howard,Graeme Smith,Peter Hillmen,Roger G Owen,Andrew S Jack,

Disease progression occurs in over 1% of monoclonal gammopathy of undetermined significance, monoclonal B-cell lymphocytosis and early stage chronic lymphocytic leukaemia patients every year therefore regular monitoring is indicated. We assessed the efficacy of an outreach service to replace clinic monitoring using local phlebotomy with central haematologist review of laboratory parameters and symptoms identified by a patient self-assessment questionnaire. The service was used by 299 patients for 2 years and provided accurate monitoring, improved patient satisfaction, support for primary care and reduced the burden on haematology clinics without an increase in inter-assessment admissions due to disease progression.

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Publishing Authors By Initials

AC Rawstron,RA Jones,C Ferguson,G Hughes,P Selby,C Reid,S Dalal,M Howard,G Smith,P Hillmen,RG Owen,AS Jack,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British journal of haematology

VOLUME: 139

Page Numbers: 845-8

Journal Abbreviation: Br. J. Haematol.

ISSN: 1365-2141

DAY: 25

MONTH: 10

YEAR: 2007

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372544

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.

AFFILIATION: HMDS Department, Leeds Teaching Hospitals, Leeds, UK. andy.rawstron@hmds.org.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Haematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience Related Publications

• 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
• A critical analysis of local anesthesia as an agent for the relief of pain in vaginal delivery.
• Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies.
• Applying comprehensive community-based approaches in diabetes prevention: rationale, principles, and models.
• Assessment of functional MR imaging in neurosurgical planning.
• Balancing Big Pharma's books.
• Bone anomalies of the tarsus in relation to peroneal spastic flat foot.
• Conserved C-terminal motifs of the Arabidopsis proteins APETALA3 and PISTILLATA are dispensable for floral organ identity function.
• Counterfeit medicines. Bitter pills.
• DORNROSCHEN-LIKE, an AP2 gene, is necessary for stamen emergence in Arabidopsis.
• EWEN ALISTAIR JACK, 1909-1953.
• Experimental rupture of the medial collateral ligament of the knee.
• Functional heterogeneity of the supplementary motor area.
• Hippocampal T2 relaxometry in epilepsy: past, present, and future.
• Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
• MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
• Medial temporal lobe volumetrics in traumatic brain injury.
• Naviculo-cuneiform fusion in the treatment of flat foot.
• Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
• Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
• Plasma ascorbic acid levels in Nigerian children of Niger delta region of Nigeria.
• Posterior peripheral detachment of the lateral cartilage.
• Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
• Relation of triglycerides to phosphoglycerides in fungi.
• Structure and dynamics of glass formers: Predictability at large length scales.
• Understanding rehospitalization risk: can hospital discharge be modified to reduce recurrent hospitalization?
• Use of milk fat fractions in baked products.
• Voxel-based morphometry in autopsy proven PSP and CBD.
• [A nurse sees her professional colleagues at the bedside of her sick mother. Nurses: competent and insensitive]
• ef1097 and ypkK encode enterococcin V583 and corynicin JK, members of a new family of antimicrobial proteins (bacteriocins) with modular structure from Gram-positive bacteria.